메뉴 건너뛰기




Volumn 17, Issue 5, 2001, Pages 856-862

High or standard initial dose of budesonide to control mild-to-moderate asthma?

Author keywords

Airway pharmacology; Budesonide; Mild to moderate asthma; Treatment strategy

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE;

EID: 0034948549     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.17508560     Document Type: Article
Times cited : (20)

References (25)
  • 3
    • 0026230417 scopus 로고
    • Guidelines for the diagnosis and management of asthma: National Heart Lung and Blood Institute, National Asthma Education Program, Expert Panel report
    • (1991) J Allergy Clin Immunol , vol.88 , pp. 425-534
  • 4
    • 0027406017 scopus 로고
    • Guidelines on the Management of Asthma
    • British Thoracic Society. British Paediatric Association, Research Unit of the Royal College of Physicians of London King's Fund Centre, National Asthma Campaign, Royal College of General Practitioners, et al.
    • (1993) Thorax , vol.48
  • 10
    • 0018774566 scopus 로고
    • Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol with a placebo in chronic bronchial asthma
    • Second report of the Brompton Hospital/Medical Research Council Collaborative Trial
    • (1979) Br J Dis Chest , vol.73 , pp. 121-132
  • 24
    • 0004646341 scopus 로고    scopus 로고
    • The Global Strategy for Asthma Management and Prevention. Based on the National Institute of Health/ WHO Workshop Report. National Heart, Lung, and Blood Institute. NIH publication No 96-3659B. November
    • (1998)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.